IXJ vs. IHE
IXJ (iShares Global Healthcare ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds from iShares - IXJ tracks the S&P Global Healthcare Sector Index while IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 10 years, IXJ returned 7.66%/yr vs 7.81%/yr for IHE. Their correlation of 0.84 suggests significant overlap in exposure. IXJ charges 0.46%/yr vs 0.42%/yr for IHE.
Performance
IXJ vs. IHE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IXJ achieves a -5.26% return, which is significantly lower than IHE's 6.47% return. Both investments have delivered pretty close results over the past 10 years, with IXJ having a 7.66% annualized return and IHE not far ahead at 7.81%.
IXJ
- 1D
- 0.39%
- 1M
- 0.34%
- YTD
- -5.26%
- 6M
- -4.88%
- 1Y
- 9.30%
- 3Y*
- 4.42%
- 5Y*
- 4.02%
- 10Y*
- 7.66%
IHE
- 1D
- 1.16%
- 1M
- 1.80%
- YTD
- 6.47%
- 6M
- 8.51%
- 1Y
- 40.15%
- 3Y*
- 17.47%
- 5Y*
- 9.98%
- 10Y*
- 7.81%
IXJ vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | -5.26% | 14.99% | 0.55% | 3.62% | -4.94% | 19.60% | 12.74% | 23.23% | 2.83% | 20.44% |
IHE iShares U.S. Pharmaceuticals ETF | 6.47% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between IXJ and IHE is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.83 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.85 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.83 |
Correlation (All Time) Calculated using the full available price history since May 8, 2006 | 0.84 |
The correlation between IXJ and IHE has been stable across timeframes, ranging from 0.83 to 0.85 - a consistent structural relationship.
IXJ vs. IHE - Sectors Allocation Comparison
Sectors
IXJ
IHE
Healthcare
Consumer Defensive
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IXJ
IHE
Consumer Defensive
IXJ
IHE
-
Basic Materials
IXJ
-
IHE
-
Communication Services
IXJ
-
IHE
-
Consumer Cyclical
IXJ
-
IHE
-
Energy
IXJ
-
IHE
-
Financial Services
IXJ
-
IHE
-
Industrials
IXJ
-
IHE
-
Real Estate
IXJ
-
IHE
-
Technology
IXJ
-
IHE
-
Utilities
IXJ
-
IHE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. IHE — Risk / Return Rank
IXJ
IHE
IXJ vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IXJ | IHE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | 2.36 | -1.72 |
Sortino ratioReturn per unit of downside risk | 1.06 | 3.43 | -2.37 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.40 | -0.28 |
Calmar ratioReturn relative to maximum drawdown | 0.87 | 4.76 | -3.89 |
Martin ratioReturn relative to average drawdown | 2.11 | 14.35 | -12.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IXJ | IHE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | 2.36 | -1.72 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | 0.62 | -0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | 0.43 | +0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.51 | -0.09 |
Drawdowns
IXJ vs. IHE - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for IXJ and IHE.
Loading charts...
Drawdown Indicators
| IXJ | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | -38.20% | -2.40% |
Max Drawdown (1Y)Largest decline over 1 year | -10.78% | -8.47% | -2.31% |
Max Drawdown (3Y)Largest decline over 3 years | -18.14% | -15.92% | -2.22% |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | -16.03% | -2.11% |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | -29.59% | +2.24% |
Current DrawdownCurrent decline from peak | -9.27% | -2.80% | -6.47% |
Average DrawdownAverage peak-to-trough decline | -6.92% | -7.92% | +1.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 2.81% | +1.60% |
Volatility
IXJ vs. IHE - Volatility Comparison
The current volatility for iShares Global Healthcare ETF (IXJ) is 3.75%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 5.53%. This indicates that IXJ experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IXJ | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.75% | 5.53% | -1.78% |
Volatility (6M)Calculated over the trailing 6-month period | 10.05% | 12.48% | -2.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.55% | 17.07% | -2.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 16.24% | -2.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.67% | 18.05% | -2.38% |
IXJ vs. IHE - Expense Ratio Comparison
IXJ has a 0.46% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
IXJ vs. IHE - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.47%, less than IHE's 1.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.65% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
IXJ iShares Global Healthcare ETF | 1.47% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
Frequently Asked Questions
IXJ and IHE have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (5.53%) compared to IXJ (3.75%). In terms of maximum drawdown, IXJ dropped -40.60% vs IHE's -38.20%.
On 10-year performance, IHE leads with 7.81% vs 7.66% for IXJ. On fees, IHE is cheaper at 0.42% per year. On volatility, IXJ has been the lower-risk option at 3.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHE has performed better with a 7.81% return vs 7.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHE is cheaper with a 0.42% expense ratio, compared with 0.46% for IXJ.
IHE has the higher dividend yield at 1.65%, compared with 1.47% for IXJ.
IXJ tracks S&P Global Healthcare Sector Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. Their fees differ too: 0.46% for IXJ and 0.42% for IHE.
IHE currently has the higher Sharpe Ratio (2.36 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IXJ and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer